These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32816175)

  • 1. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density.
    Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z
    Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production Process Development of Pseudorabies Virus Vaccine by Using a Novel Scale-Down Model of a Fixed-Bed Bioreactor.
    Nie J; Sun Y; Peng F; Li X; Yang Y; Liu X; Li Y; Liu C; Bai Z
    J Pharm Sci; 2020 Feb; 109(2):959-965. PubMed ID: 31604085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach.
    Nie J; Sun Y; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z
    Cytotechnology; 2020 Apr; 72(2):283-293. PubMed ID: 32086694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on high-density cultivation of Vero cells with biosilon solid microcarrier.
    Wang D; Xiao C; Chen Z; Huang Z
    Chin J Biotechnol; 1996; 12(2):119-29. PubMed ID: 8988358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
    Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R
    Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.
    Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA
    Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
    Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an HSV-1 production process involving serum-reduced culturing and bead-to-bead transfer.
    Wang H; Hu X; Zhang M; Yang L; Xu Y; Gu X; Jiang J; Hu W
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):383. PubMed ID: 38896301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
    Berrie DM; Waters RC; Montoya C; Chatel A; Vela EM
    Vaccine; 2020 Apr; 38(20):3639-3645. PubMed ID: 32247568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium.
    Mattos DA; Silva MV; Gaspar LP; Castilho LR
    Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
    Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U
    Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods.
    Thomassen YE; Rubingh O; Wijffels RH; van der Pol LA; Bakker WA
    Vaccine; 2014 May; 32(24):2782-8. PubMed ID: 24583004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, optimization, and scale-up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus-1.
    Shen CF; Burney E; Gilbert R; Elahi SM; Parato K; Loignon M
    Biotechnol J; 2024 Jan; 19(1):e2300244. PubMed ID: 37767876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed.
    Kiesslich S; Vila-Chã Losa JP; Gélinas JF; Kamen AA
    J Biotechnol; 2020 Feb; 310():32-39. PubMed ID: 32006630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aujeszky's disease virus production in disposable bioreactor.
    Slivac I; Srcek VG; Radosevic K; Kmetic I; Kniewald Z
    J Biosci; 2006 Sep; 31(3):363-8. PubMed ID: 17006019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.